Published in Blood Weekly, March 31st, 1997
AHF was developed in an ongoing effort to provide an added measure of viral safety for plasma derived biopharmaceutical products. Alphanate Antihemophilic Factor (Human), Solvent Detergent/Heat Treated is the first AHF product in the U.S. that incorporates solvent detergent and heat treatment methods of viral inactivation.
The first step incorporated by Alpha solvent detergent treatment inactivates...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.